A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE

Clinical Immunology

Volumn 126, Issue 2, 2008, Pages 189-201

  Nicholas, Matilda W ^a   Dooley, Mary Anne ^a   Hogan, Susan L ^a   Anolik, Jennifer ^b   Looney, John ^b   Sanz, Ingnacio ^b   Clarke, Stephen H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Autoimmunity; B lymphocytes; CD19; Memory B cells; Sm antigen; Systemic lupus erythematosus

Indexed keywords

CD19 ANTIBODY; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE SYK; SM ANTIBODY;

ADULT; ADVERSE OUTCOME; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BASAL CELL; CELL CLONING; CELL CYCLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; FEMALE; HUMAN; IN VITRO STUDY; INFLAMMATION; MALE; MEMORY CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CHEMOKINE CXCL9; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLASMA CELLS; RECEPTORS, CXCR3; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 37849047224     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.10.004     Document Type: Article

References (73)

1. Hahn B.H. Antibodies to DNA. N. Engl. J. Med. 338 (1998) 1359-1368
2. Su W., and Madaio M.P. Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin. Nephrol. 23 (2003) 564-568
3. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., Johnson L.L., Swain S.L., and Lund F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1 (2000) 475-482
4. Bijl M., Horst G., Limburg P.C., and Kallenberg C.G. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 60 (2001) 523-526
5. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 (1999) 1639-1648
6. Shlomchik M.J., Madaio M.P., Ni D., Trounstein M., and Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180 (1994) 1295-1306
7. Chan O.T., Madaio M.P., and Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169 (1999) 107-121
8. Roth R., Gee R.J., and Mamula M.J. B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann. N.Y. Acad. Sci. 815 (1997) 88-104
9. Mamula M.J., Fatenejad S., and Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152 (1994) 1453-1461
10. Ehrhardt G.R., Hsu J.T., Gartland L., Leu C.M., Zhang S., Davis R.S., and Cooper M.D. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202 (2005) 783-791
11. Fecteau J.F., Cote G., and Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J. Immunol. 177 (2006) 3728-3736
12. Wei C., Anolik J.H., Cappione A., Huggins J., Zheng B., Milner E., and Sanz I. A new population of cell lacking expression of C27 represents a notable component of the B cell memory compartment in SLE. J. Immunol. 178 (2007)
13. Anolik J.H., Barnard J., Cappione A., Pugh-Bernard A.E., Felgar R.E., Looney R.J., and Sanz I. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 3580-3590
14. Odendahl M., Jacobi A., Hansen A., Feist E., Hiepe F., Burmester G.R., Lipsky P.E., Radbruch A., and Dorner T. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165 (2000) 5970-5979
15. Tedder T.F., Zhou L.J., and Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15 (1994) 437-442
16. Tedder T.F., Inaoki M., and Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6 (1997) 107-118
17. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., and Tedder T.F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149 (1992) 2841-2850
18. Uckun F.M., Burkhardt A.L., Jarvis L., Jun X., Stealey B., Dibirdik I., Myers D.E., Tuel-Ahlgren L., and Bolen J.B. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 268 (1993) 21172-21184
19. Xiao J., Messinger Y., Jin J., Myers D.E., Bolen J.B., and Uckun F.M. Signal transduction through the beta1 integrin family surface adhesion molecules VLA-4 and VLA-5 of human B-cell precursors activates CD19 receptor-associated protein-tyrosine kinases. J. Biol. Chem. 271 (1996) 7659-7664
20. Kitanaka A., Ito C., Coustan-Smith E., and Campana D. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J. Immunol. 159 (1997) 184-192
21. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., and Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3 (1995) 39-50
22. Sato S., Steeber D.A., and Tedder T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11558-11562
23. Inaoki M., Sato S., Weintraub B.C., Goodnow C.C., and Tedder T.F. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186 (1997) 1923-1931
24. Sato S., Hasegawa M., Fujimoto M., Tedder T.F., and Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165 (2000) 6635-6643
25. Fujimoto M., Fujimoto Y., Poe J.C., Jansen P.J., Lowell C.A., DeFranco A.L., and Tedder T.F. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13 (2000) 47-57
26. DeFranco A.L., Chan V.W., and Lowell C.A. Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin. Immunol. 10 (1998) 299-307
27. Niiro H., and Clark E.A. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev., Immunol. 2 (2002) 945-956
28. Fujimoto M., Poe J.C., Jansen P.J., Sato S., and Tedder T.F. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162 (1999) 7088-7094
29. Li X., and Carter R.H. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. J. Immunol. 161 (1998) 5901-5908
30. Culton D.A., Nicholas M.W., Bunch D.O., Zhen Q.L., Kepler T.B., Dooley M.A., Mohan C., Nachman P.H., and Clarke S.H. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J. Clin. Immunol. 27 (2007) 53-68
31. Sato S., Fujimoto M., Hasegawa M., and Takehara K. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum. 50 (2004) 1918-1927
32. Wehr C., Eibel H., Masilamani M., Illges H., Schlesier M., Peter H.H., and Warnatz K. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113 (2004) 161-171
33. Warnatz K., Wehr C., Drager R., Schmidt S., Eibel H., Schlesier M., and Peter H.H. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 206 (2002) 502-513
34. Culton D.A., O'Conner B.P., Conway K.L., Diz R., Rutan J., Vilen B.J., and Clarke S.H. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 176 (2006) 790-802
35. J.H. Anolik, J. Barnard, T. Owen, B. Zheng, S. Kemshetti, R.J. Looney, and I. Sanz, Recovery of peripheral blood memory B cells after rituximab treatment in SLE is delayed and lags behind lymphoid tissue memory B cell reconstitution. Arthritis Rheum. (in press).
36. Looney R.J., Anolik J.H., Campbell D., Felgar R.E., Young F., Arend L.J., Sloand J.A., Rosenblatt J., and Sanz I. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 50 (2004) 2580-2589
37. Lankester A.C., Rood P.M., van Schijndel G.M., Hooibrink B., Verhoeven A.J., and van Lier R.A. Alteration of B-cell antigen receptor signaling by CD19 co-ligation. A study with bispecific antibodies. J. Biol. Chem. 271 (1996) 22326-22330
38. Rui L., Vinuesa C.G., Blasioli J., and Goodnow C.C. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4 (2003) 594-600
39. Budman D.R., Merchant E.B., Steinberg A.D., Doft B., Gershwin M.E., Lizzio E., and Reeves J.P. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum. 20 (1977) 829-833
40. Blaese R.M., Grayson J., and Steinberg A.D. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am. J. Med. 69 (1980) 345-350
41. Liossis S.N., Kovacs B., Dennis G., Kammer G.M., and Tsokos G.C. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J. Clin. Invest. 98 (1996) 2549-2557
42. Tsokos G.C., Wong H.K., Enyedy E.J., and Nambiar M.P. Immune cell signaling in lupus. Curr. Opin. Rheumatol. 12 (2000) 355-363
43. Tangye S.G., Liu Y.J., Aversa G., Phillips J.H., and de Vries J.E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188 (1998) 1691-1703
44. Lin K.I., Angelin-Duclos C., Kuo T.C., and Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22 (2002) 4771-4780
45. Lopez F., Belloc F., Lacombe F., Dumain P., Reiffers J., Bernard P., and Boisseau M.R. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 12 (1991) 42-49
46. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182 (2000) 311-322
47. Loke P., MacDonald A.S., Robb A., Maizels R.M., and Allen J.E. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30 (2000) 2669-2678
48. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., and Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391 (1998) 799-803
49. Hargreaves D.C., Hyman P.L., Lu T.T., Ngo V.N., Bidgol A., Suzuki G., Zou Y.R., Littman D.R., and Cyster J.G. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194 (2001) 45-56
50. Muehlinghaus G., Cigliano L., Huehn S., Peddinghaus A., Leyendeckers H., Hauser A.E., Hiepe F., Radbruch A., Arce S., and Manz R.A. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105 (2005) 3965-3971
51. Hauser A.E., Debes G.F., Arce S., Cassese G., Hamann A., Radbruch A., and Manz R.A. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169 (2002) 1277-1282
52. Odendahl M., Mei H., Hoyer B.F., Jacobi A.M., Hansen A., Muehlinghaus G., Berek C., Hiepe F., Manz R., Radbruch A., and Dorner T. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105 (2005) 1614-1621
53. Loetscher M., Loetscher P., Brass N., Meese E., and Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 28 (1998) 3696-3705
54. Otero D.C., Omori S.A., and Rickert R.C. Cd19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276 (2001) 1474-1478
55. Pogue S.L., Kurosaki T., Bolen J., and Herbst R. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J. Immunol. 165 (2000) 1300-1306
56. Martin P., Duran A., Minguet S., Gaspar M.L., Diaz-Meco M.T., Rennert P., Leitges M., and Moscat J. Role of zeta PKC in B-cell signaling and function. EMBO J. 21 (2002) 4049-4057
57. Reimold A.M., Ponath P.D., Li Y.S., Hardy R.R., David C.S., Strominger J.L., and Glimcher L.H. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183 (1996) 393-401
58. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., and Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13 (2000) 199-212
59. Lin K.I., Tunyaplin C., and Calame K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194 (2003) 19-28
60. Shaffer A.L., Lin K.I., Kuo T.C., Yu X., Hurt E.M., Rosenwald A., Giltnane J.M., Yang L., Zhao H., Calame K., and Staudt L.M. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17 (2002) 51-62
61. Cyster J.G. Homing of antibody secreting cells. Immunol. Rev. 194 (2003) 48-60
62. Cassese G., Arce S., Hauser A.E., Lehnert K., Moewes B., Mostarac M., Muehlinghaus G., Szyska M., Radbruch A., and Manz R.A. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171 (2003) 1684-1690
63. Cassese G., Lindenau S., de Boer B., Arce S., Hauser A., Riemekasten G., Berek C., Hiepe F., Krenn V., Radbruch A., and Manz R.A. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 31 (2001) 2726-2732
64. Tsubaki T., Takegawa S., Hanamoto H., Arita N., Kamogawa J., Yamamoto H., Takubo N., Nakata S., Yamada K., Yamamoto S., Yoshie O., and Nose M. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin. Exp. Immunol. 141 (2005) 363-371
65. Meller S., Winterberg F., Gilliet M., Muller A., Lauceviciute I., Rieker J., Neumann N.J., Kubitza R., Gombert M., Bunemann E., Wiesner U., Franken-Kunkel P., Kanzler H., Dieu-Nosjean M.C., Amara A., Ruzicka T., Lehmann P., Zlotnik A., and Homey B. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum. 52 (2005) 1504-1516
66. Lit L.C., Wong C.K., Tam L.S., Li E.K., and Lam C.W. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65 (2006) 209-215
67. Narumi S., Takeuchi T., Kobayashi Y., and Konishi K. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine 12 (2000) 1561-1565
68. Avihingsanon Y., Phumesin P., Benjachat T., Akkasilpa S., Kittikowit V., Praditpornsilpa K., Wongpiyabavorn J., Eiam-Ong S., Hemachudha T., Tungsanga K., and Hirankarn N. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int. 69 (2006) 747-753
69. Okamoto H., Katsumata Y., Nishimura K., and Kamatani N. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum. 50 (2004) 3731-3732
70. Okamoto H., Iikuni N., Kamitsuji S., Yoshio T., Minota S., and Kamatani N. IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology (Oxford) 45 (2006) 232-234
71. Hirohata S., and Miyamoto T. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement. J. Rheumatol. 13 (1986) 715-721
72. Sfikakis P.P., Boletis J.N., and Tsokos G.C. Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future. Curr. Opin. Rheumatol. 17 (2005) 550-557
73. Martin F., and Chan A.C. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24 (2006) 467-496